BSV163/DOPE‐mediated TRAIL gene transfection acts synergistically with chemotherapy against cisplatin‐resistant ovarian cancer.
Saved in:
| Title: | BSV163/DOPE‐mediated TRAIL gene transfection acts synergistically with chemotherapy against cisplatin‐resistant ovarian cancer. |
|---|---|
| Authors: | Nguyen, Quoc Manh1 (AUTHOR), Dupré, Pierre‐François1,2 (AUTHOR), Berchel, Mathieu3 (AUTHOR), Ghanem, Rosy1,4 (AUTHOR), Jaffrès, Paul‐Alain3 (AUTHOR), d'Arbonneau, Frédérique1,5 (AUTHOR) frederique.darbonneau‐loreau@univ‐brest.fr, Montier, Tristan1,4,6 (AUTHOR) tristan.montier@univ‐brest.fr |
| Source: | Chemical Biology & Drug Design. Jan2024, Vol. 103 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
